Results 171 to 180 of about 20,472,724 (278)

Extended hydrogen breath test analysis for optimized diagnosis of SIBO-positive IBS patients. [PDF]

BMC Gastroenterol
Dahlgren A, Grybäck P, Jacobsson H, Hellström PM.   +3 more
europepmc   +1 more source

v. 80, issue 4, March 1, 2013 [PDF]

, 2013

core   +1 more source

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

Molecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena, Karin Teien Lande, Eva Diaz, Ana Vilar, Juan Cueva, Efigenia Arias, Victoria Sampayo, Alicia Abalo, Nerea González, Eva Colás, Antonio Gil‐Moreno, Miguel Abal, Gema Moreno‐Bueno, Therese Sørlie, Kristina Lindemann, Laura Muinelo‐Romay   +15 more
wiley   +1 more source

How the brain predicts timing: distinct network hubs for predicting and evaluating auditory sensory events. [PDF]

Front Neurosci
Nagy P, Kovács P, Boncz Á, Szalárdy O, Baumgartner R, Ignatiadis K, Winkler I, Tóth B.   +7 more
europepmc   +1 more source

v. 80, issue 17, April 5, 2013 [PDF]

, 2013

core   +1 more source

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

Molecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen, Kristiane Søreng, Chiara Veroni, Laura Trachsel‐Moncho, Nagham Asp, Robin Gaupset, Lars Gustav Lyckander, Helene Knævelsrud, Lars Eftang, Anne Simonsen   +9 more
wiley   +1 more source

Impact of inactivation methods on biosafety and antigen reactivity of Brucella melitensis from the perspective of Astral-DIA proteomics based on antibody immunoprecipitation mass spectrometry. [PDF]

PLoS Negl Trop Dis
Liu Y, Ge J, Song G, Gao P, Qi M, Wang W, Xie Y, Wang Z, Li R, Chu Y, Zheng F.   +10 more
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Occupational burnout and job satisfaction among nurses in designated infectious disease hospitals: a correlational study. [PDF]

Front Public Health
Liu W, Li S, Wang J, Wang F.
europepmc   +1 more source

v. 80, issue 18, April 12, 2013 [PDF]

, 2013

core   +1 more source